Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Spotlight on NK antagonists for asthma

May 7, 1998

PDE IV inhibitors focus of attention at recent respiratory care congress

May 7, 1998

Phosphodiesterase inhibitors with antiasthmatic efficacy

May 7, 1998

CytoMed's 5-LO inhibitor shows potential in asthma; clinical trials imminent

May 6, 1998

SB-240563, an anti-IL-5 MAb for the treatment of asthma

May 6, 1998

Spotlight on P2Y2 agonists: a new target for cystic fibrosis

May 6, 1998

Surfaxin as ARDS treatment enters phase II/III

May 5, 1998

Nebulized furosemide beneficial in patients with acute asthma of short-term duration

May 4, 1998

AxyS Pharmaceuticals' APC-366 shows good antiasthmatic activity in phase IIa trial

May 1, 1998

New PDE IV inhibitors for asthma reported by Celltech

April 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...